Context Therapeutics, Inc. (CNTX)
0.1935
+0.01
(+2.98%)
USD |
NASDAQ |
Nov 06, 16:00
0.1942
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Cash from Operations (Quarterly) : -7.020M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.020M |
| March 31, 2026 | -11.43M |
| December 31, 2025 | -8.943M |
| September 30, 2025 | -6.579M |
| June 30, 2025 | -5.835M |
| March 31, 2025 | -5.028M |
| December 31, 2024 | -4.907M |
| September 30, 2024 | -1.933M |
| June 30, 2024 | -3.356M |
| March 31, 2024 | -4.361M |
| December 31, 2023 | -7.227M |
| September 30, 2023 | -3.461M |
| June 30, 2023 | -4.631M |
| Date | Value |
|---|---|
| March 31, 2023 | -5.728M |
| December 31, 2022 | -3.930M |
| September 30, 2022 | -2.994M |
| June 30, 2022 | -2.805M |
| March 31, 2022 | -3.820M |
| December 31, 2021 | -4.962M |
| September 30, 2021 | -0.0436M |
| June 30, 2021 | -2.079M |
| March 31, 2021 | -1.715M |
| December 31, 2020 | |
| September 30, 2020 | -0.3502M |
| June 30, 2020 | -0.321M |
| March 31, 2020 | -0.1874M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| EyePoint, Inc. | -62.35M |
| Neumora Therapeutics, Inc. | -39.97M |
| LENZ Therapeutics, Inc. | -22.31M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 142.89M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.518M |
| Free Cash Flow | -40.53M |
| Free Cash Flow Per Share (Quarterly) | -0.1212 |
| Free Cash Flow to Equity (Quarterly) | -11.50M |
| Free Cash Flow to Firm (Quarterly) | -11.54M |
| Free Cash Flow Yield | -222.0% |